To screen ETFs by asset class, performance, yield and more, check out the
"FDA staff says NPS Pharma's (
) bowel drug needs no safety restrictions." Drug may be nearing approval.
Add a reply...
Latest StockTalks »
people get NPSP breaking news and analysis by email alert.
Get email alerts on NPSP »
NPS Pharmaceuticals, Inc.
Get latest price
From other sites
NPS Pharmaceuticals, Inc. (NPSP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
at Zacks.com (Nov 13, 2014)
NPS Pharmaceuticals Incurs Wider Q3 Loss, Revenues Miss - Analyst Blog
at Zacks.com (Nov 11, 2014)
Street Talk: Lorillard gets upgraded
at CNBC.com (Oct 24, 2014)
Midday movers: Apple, Netflix, RadioShack & more
at CNBC.com (Sep 15, 2014)
Midday movers: Caterpillar, RadioShack, Tiffany & more
at CNBC.com (Sep 10, 2014)
Xignite quote data
© 2014 Seeking Alpha